Opus Genetics, Stock Today
| IRD Stock | 1.11 0.06 5.71% |
Performance0 of 100
| Odds Of DistressOver 75
|
Opus Genetics, is trading at 1.11 as of the 1st of December 2024, a 5.71% up since the beginning of the trading day. The stock's lowest day price was 1.05. Opus Genetics, has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Opus Genetics, symbol was changed from OCUP on 24th of October 2024. Equity ratings for Opus Genetics, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of December 2022 and ending today, the 1st of December 2024. Click here to learn more.
IPO Date 23rd of May 2005 | Category Healthcare |
Opus Genetics, is entity of United States. It is traded as Stock on NASDAQ exchange. More on Opus Genetics,
Moving together with Opus Stock
| 0.72 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
Moving against Opus Stock
Opus Stock Highlights
| Older Symbol | OCUP | |||||||||||||||||||||||||||||||||||
| CEO Director | MBA MD | |||||||||||||||||||||||||||||||||||
| Old Name | Groupe IRD | |||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Opus Genetics, (IRD) is traded on NASDAQ Exchange in USA. It is located in 37000 Grand River Avenue, Farmington Hills, MI, United States, 48335 and employs 14 people. Opus Genetics, was previously known as Ocuphire Pharma and was traded on NASDAQ Exchange under the symbol OCUP. Opus Genetics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company runs under Healthcare sector within Biotechnology industry.
Opus Genetics, generates negative cash flow from operations
Check Opus Genetics, Probability Of Bankruptcy
Opus Genetics, Historical Income Statement
Opus Stock Against Markets
Opus Genetics, Corporate Management
| Joseph MBA | Chief Officer | Profile | |
| Bernhard MBA | Senior Secretary | Profile | |
| Ashwath Jayagopal | Chief Officer | Profile | |
| Bindu Manne | Head Commercialization | Profile | |
| MAcc CPA | Senior Finance | Profile | |
| Nirav CFA | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.